JETEMA, Co., Ltd. (KOSDAQ:216080)

South Korea · Delayed Price · Currency is KRW

5,830.00

-80.00 (-1.35%)

Nov 6, 2026, 3:30 PM KST

Market Cap	217.38B +5.4%
Revenue (ttm)	76.58B +8.8%
Net Income	-1.33B
EPS	-37.03
Shares Out	37.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	149,742
Open	5,700.00
Previous Close	5,910.00
Day's Range	5,600.00 - 6,000.00
52-Week Range	3,800.00 - 11,280.00
Beta	0.57
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About JETEMA,

JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers clostridium botulinum toxins, fillers, lifting threads for medical treatment, elastin and collagen stimulate solution under Ecolla, and healthy skin care under vitten brand names. The company also provides skin care hyaluronic acid masks. JETEMA, Co., Ltd. was founded in 2009 and is headquartered in Wonju-si, South Korea. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2009

Employees 265

Stock Exchange KOSDAQ

Ticker Symbol 216080

Full Company Profile

Financial Performance

In 2025, JETEMA,'s revenue was 76.90 billion, an increase of 12.23% compared to the previous year's 68.52 billion. Losses were -6.60 billion, 3407.4% more than in 2024.

Financial Statements